55 filings
Page 3 of 3
8-K
v13bmn
16 Jun 20
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
c0omq8gaxdhd1lfyrer
12 May 20
Adaptive Biotechnologies Reports First Quarter 2020 Financial Results
4:15pm
8-K
9n5yg5mbka mpr
5 May 20
Regulation FD Disclosure
12:00pm
8-K
zdtx856
20 Mar 20
Adaptive Biotechnologies and Microsoft expand partnership to decode COVID-19 immune response and provide open data access
2:13pm
8-K
4pt40mdgyo2
26 Feb 20
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2019 Financial Results
4:15pm
8-K
teihc1 kit
18 Feb 20
Departure of Directors or Certain Officers
7:00am
8-K/A
6zjfihcq e3
24 Jan 20
Adaptive Announces Preliminary Unaudited Revenue for About Adaptive Biotechnologies
9:16pm
8-K
e2t2f3k
23 Jan 20
Adaptive Announces Proposed Public Offering of Common Stock
9:04pm
8-K
looa54ybxn19eqg
8 Jan 20
Adaptive Biotechnologies Receives Expanded Medicare Coverage of clonoSEQ® for Monitoring MRD in Patients With Chronic Lymphocytic Leukemia
9:00am
8-K
goqwn1hp9q0hy5
12 Nov 19
Adaptive Biotechnologies Corporation Reports Third Quarter 2019 Financial Results
4:15pm
8-K
g57208jbpo5zia9u
24 Sep 19
Adaptive Biotechnologies Enters Partnership with Illumina to Develop Distributable IVD Test Kits for clonoSEQ and immunoSEQ Dx
5:01pm
8-K
mxom3krlo1z g84mv
13 Aug 19
Adaptive Biotechnologies Corporation Reports Second Quarter 2019 Financial Results
4:15pm
8-K
se2pd6
7 Aug 19
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling its Footprint in Seattle’s Growing Biotech Hub
5:29pm
8-K
9jzm8u6kk8c1ct
2 Aug 19
Adaptive Biotechnologies Receives New York State CLEP Approval for clonoSEQ to Detect
4:54pm
8-K
yst6kbakmmfab58 sp1
1 Jul 19
Adaptive Biotechnologies Announces Pricing of Initial Public Offering
4:41pm